September is Blood Cancer Awareness Month

September is Blood Cancer Awareness Month

FOSTER CITY, CALIF. – Aug. 06, 2020 – Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, announced a new precision oncology study with Washington University School of Medicine in St. Louis, exploring the feasibility of ex vivo drug screening to predict sensitivity and resistance to chemotherapy, and to identify novel synergies across a broad panel of anti-cancer therapies.

Notable’s Mission to Move Beyond a  “One-Size-Fits-All” <em>Ex Vivo</em> Drug Sensitivity Test

Notable’s Mission to Move Beyond a “One-Size-Fits-All” Ex Vivo Drug Sensitivity Test

Figure 1: Heatmap showing responses to 31 drugs or drug combinations (rows) in 37 blood cancer patient samples (columns). Each colored box represents the level of ex vivo drug sensitivity, with red indicating the highest level of sensitivity and blue the lowest. Getting the right cancer drugs to the right patients relies on the accurate […]

Notable’s The ANSWer Study

Notable’s The ANSWer Study

Notable’s The ANSWer Study: An Observational Clinical Trial for Patients with Blood Cancer by Susanna Wen MsM (Master of Medicine), Ph.D Notable’s first self-sponsored clinical trial to validate cancer patient matching on its automated high-throughput scientific technology platform At Notable, we are aiming to redefine cancer treatment with the development of a functional precision medicine […]

What is precision medicine?

What is precision medicine?

In the world of oncology, precision medicine has been synonymous with genomics. Once genetic abnormalities are identified in a patient through cytogenetics and sequencing, an appropriate therapy can be identified that exploits this abnormality thought to be driving cancer growth. One of the best success stories… oncology precision medicine has been the genetic.

Why I Joined Notable

,

Why I Joined Notable

“What’s next?” For me, the simple answer to this question is joining a life sciences tech startup to build and lead a clinical development organization. But the reasons behind my move from a successful and well-respected East Coast biotech (and a job I absolutely loved) is part of a much more complicated complex answer to […]

Notable Founder Pete Quinzio Reflects on his 2018 Man of the Year Experience

,

Notable Founder Pete Quinzio Reflects on his 2018 Man of the Year Experience

Pete Quinzio (Notable Labs) & Catherine Finn (Salesforce) 2018 Bay Area Man and Woman of the Year At Notable we are immensely proud of Founder, Pete Quinzio who recently raised over $200,000 in 10 weeks for leukemia and lymphoma research. As nominations open for 2019 we sat down with Pete to ask him about his […]